Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 2.13 is 99% above its 4-year average of 1.07, near the high end of its 4-year range (0.00–2.13).
As of the fiscal period ended Tuesday, June 30, 2026. 2.60% above its 12-month average of 2.08.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.13.
DEBT TO EQUITY RATIO
2.13
DEBT TO EQUITY RATIO AVG TTM
2.08
DEBT TO EQUITY RATIO AVG 3Y
1.41
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.60%
CURRENT VS 3Y AVG
+50.82%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.66
median of 94 covered companies
CURRENT VS SECTOR MEDIAN
+225.47%
vs the sector median at left
Fortrea Holdings Inc.
Market Cap
$1.90B
Debt to Equity Ratio
2.13
TTM Avg
2.08
3Y Avg
1.41
5Y Avg
N/A
Market Cap
$1.74B
Debt to Equity Ratio
1.71
TTM Avg
1.50
3Y Avg
1.07
5Y Avg
0.87
Market Cap
$1.71B
Debt to Equity Ratio
0.10
TTM Avg
0.19
3Y Avg
0.15
5Y Avg
0.12
Market Cap
$2.16B
Debt to Equity Ratio
0.07
TTM Avg
0.09
3Y Avg
0.10
5Y Avg
0.08
Market Cap
$2.52B
Debt to Equity Ratio
0.23
TTM Avg
0.23
3Y Avg
0.22
5Y Avg
0.25
Market Cap
$2.76B
Debt to Equity Ratio
1.67
TTM Avg
1.63
3Y Avg
1.85
5Y Avg
1.39
Market Cap
$1.00B
Debt to Equity Ratio
0.79
TTM Avg
0.91
3Y Avg
0.80
5Y Avg
0.56
Market Cap
$474.59M
Debt to Equity Ratio
0.57
TTM Avg
0.61
3Y Avg
0.62
5Y Avg
0.56
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | $1.90B | 2.13 | 2.08 | 1.41 | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 1.71 | 1.50 | 1.07 | 0.87 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 0.10 | 0.19 | 0.15 | 0.12 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | 0.07 | 0.09 | 0.10 | 0.08 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | 0.23 | 0.23 | 0.22 | 0.25 |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 1.67 | 1.63 | 1.85 | 1.39 |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 0.79 | 0.91 | 0.80 | 0.56 |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | 0.57 | 0.61 | 0.62 | 0.56 |
| NRC Health (NRC)vs › | $458.62M | 13.75 | 3.86 | 2.21 | 1.62 |
| Shoulder Innovations, Inc. (SI)vs › | $394.23M | 0.12 | 0.11 | 0.11 | 0.11 |
Debt/Equity
2.13
Current Ratio
0.96
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 2.13 |
| 2026-03-31 | 2.13 |
| 2025-12-31 | 1.98 |
| 2025-09-30 | 2.04 |
| 2025-06-30 | 2.11 |
| 2025-03-31 | 1.50 |
| 2024-12-31 | 0.88 |
| 2024-09-30 | 0.80 |
| 2024-06-30 | 0.82 |
| 2024-03-31 | 1.06 |
| 2023-12-31 | 0.98 |
| 2023-09-30 | 1.00 |
| 2023-06-30 | 0.96 |
| 2023-03-31 | 0.92 |
| 2022-12-31 | 0.02 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
